<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d349" origId="Neostigmine"><sentence id="DrugDDI.d349.s0" origId="s0" text="Certain antibiotics, especially neomycin, streptomycin and kanamycin, have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block."><entity id="DrugDDI.d349.s0.e0" origId="s0.p0" charOffset="8-19" type="drug" text="antibiotics"/><entity id="DrugDDI.d349.s0.e1" origId="s0.p1" charOffset="32-40" type="drug" text="neomycin"/><entity id="DrugDDI.d349.s0.e2" origId="s0.p2" charOffset="42-54" type="drug" text="streptomycin"/><entity id="DrugDDI.d349.s0.e3" origId="s0.p4" charOffset="59-68" type="drug" text="kanamycin"/><pair id="DrugDDI.d349.s0.p0" e1="DrugDDI.d349.s0.e0" e2="DrugDDI.d349.s0.e1" interaction="false"/><pair id="DrugDDI.d349.s0.p1" e1="DrugDDI.d349.s0.e0" e2="DrugDDI.d349.s0.e2" interaction="false"/><pair id="DrugDDI.d349.s0.p2" e1="DrugDDI.d349.s0.e0" e2="DrugDDI.d349.s0.e3" interaction="false"/><pair id="DrugDDI.d349.s0.p3" e1="DrugDDI.d349.s0.e1" e2="DrugDDI.d349.s0.e2" interaction="false"/><pair id="DrugDDI.d349.s0.p4" e1="DrugDDI.d349.s0.e1" e2="DrugDDI.d349.s0.e3" interaction="false"/><pair id="DrugDDI.d349.s0.p5" e1="DrugDDI.d349.s0.e2" e2="DrugDDI.d349.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d349.s1" origId="s1" text="These antibiotics should be used in the myasthenic patient only where definitely indicated, and then careful adjustment should be made of adjunctive anticholinesterase dosage."><entity id="DrugDDI.d349.s1.e0" origId="s1.p13" charOffset="6-17" type="drug" text="antibiotics"/><entity id="DrugDDI.d349.s1.e1" origId="s1.p25" charOffset="149-167" type="drug" text="anticholinesterase"/><pair id="DrugDDI.d349.s1.p0" e1="DrugDDI.d349.s1.e0" e2="DrugDDI.d349.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d349.s2" origId="s2" text="Local and some general anesthetics, antiarrhythmic agents and other drugs that interfere with neuromuscular transmission should be used cautiously, if at all, in patients with myasthenia gravis;"><entity id="DrugDDI.d349.s2.e0" origId="s2.p28" charOffset="15-34" type="drug" text="general anesthetics"/><entity id="DrugDDI.d349.s2.e1" origId="s2.p29" charOffset="36-56" type="drug" text="antiarrhythmic agent"/><entity id="DrugDDI.d349.s2.e2" origId="s2.p31" charOffset="68-73" type="drug" text="drugs"/><pair id="DrugDDI.d349.s2.p0" e1="DrugDDI.d349.s2.e0" e2="DrugDDI.d349.s2.e1" interaction="false"/><pair id="DrugDDI.d349.s2.p1" e1="DrugDDI.d349.s2.e0" e2="DrugDDI.d349.s2.e2" interaction="false"/><pair id="DrugDDI.d349.s2.p2" e1="DrugDDI.d349.s2.e1" e2="DrugDDI.d349.s2.e2" interaction="false"/></sentence><sentence id="DrugDDI.d349.s3" origId="s3" text="the dose of Prostigmin may have to be increased accordingly."><entity id="DrugDDI.d349.s3.e0" origId="s3.p45" charOffset="12-22" type="drug" text="Prostigmin"/></sentence></document>